These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7944302)

  • 21. Nigrofrontal dopaminergic function as assessed by 18F-dopa PET.
    Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Fukumura T; Masuda K
    Nucl Med Commun; 1995 Dec; 16(12):1021-5. PubMed ID: 8719983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism.
    Vingerhoets FJ; Snow BJ; Lee CS; Schulzer M; Mak E; Calne DB
    Ann Neurol; 1994 Nov; 36(5):759-64. PubMed ID: 7979222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults.
    Wong KK; Müller ML; Kuwabara H; Studenski SA; Bohnen NI
    J Clin Neurosci; 2012 Jan; 19(1):183-4. PubMed ID: 22030267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy.
    Hashimoto M; Kawasaki K; Suzuki M; Mitani K; Murayama S; Mishina M; Oda K; Kimura Y; Ishiwata K; Ishii K; Inoue K
    Neuroreport; 2008 Jan; 19(2):145-50. PubMed ID: 18185098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
    Rissanen E; Paavilainen T; Virta J; Marttila RJ; Rinne JO; Airas L
    Neurotoxicology; 2010 Aug; 31(4):403-7. PubMed ID: 20346372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family.
    Kishore A; Wszolek ZK; Snow BJ; de la Fuente-Fernandez R; Arwert F; Wijker M; Schulzer M; Calne DB; Vingerhoets FJ
    Neurology; 1996 Dec; 47(6):1588-90. PubMed ID: 8960754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorodopa PET scanning in Parkinson's disease.
    Snow BJ
    Adv Neurol; 1996; 69():449-57. PubMed ID: 8615165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
    Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
    Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
    Cordes M; Snow BJ; Morrison S; Sossi V; Ruth TJ; Calne DB
    Neuroradiology; 1993; 35(6):404-9. PubMed ID: 8377907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of the smell identification test for nigrostriatal dopaminergic depletion in Korean tremor patients.
    Hong JY; Chung SJ; Lee JE; Sunwoo MK; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1018-21. PubMed ID: 23920135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.
    Pate BD; Snow BJ; Hewitt KA; Morrison KS; Ruth TJ; Calne DB
    J Nucl Med; 1991 Jun; 32(6):1246-51. PubMed ID: 1904482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of radiotracer imaging in Parkinson disease.
    Ravina B; Eidelberg D; Ahlskog JE; Albin RL; Brooks DJ; Carbon M; Dhawan V; Feigin A; Fahn S; Guttman M; Gwinn-Hardy K; McFarland H; Innis R; Katz RG; Kieburtz K; Kish SJ; Lange N; Langston JW; Marek K; Morin L; Moy C; Murphy D; Oertel WH; Oliver G; Palesch Y; Powers W; Seibyl J; Sethi KD; Shults CW; Sheehy P; Stoessl AJ; Holloway R
    Neurology; 2005 Jan; 64(2):208-15. PubMed ID: 15668415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic dopaminergic function in the striatum of schizophrenic patients.
    Dao-Castellana MH; Paillère-Martinot ML; Hantraye P; Attar-Lévy D; Rémy P; Crouzel C; Artiges E; Féline A; Syrota A; Martinot JL
    Schizophr Res; 1997 Feb; 23(2):167-74. PubMed ID: 9061812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
    de la Fuente-Fernández R; Pal PK; Vingerhoets FJ; Kishore A; Schulzer M; Mak EK; Ruth TJ; Snow BJ; Calne DB; Stoessl AJ
    J Neural Transm (Vienna); 2000; 107(1):49-57. PubMed ID: 10809403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
    Shinotoh H; Snow BJ; Chu NS; Huang CC; Lu CS; Lee C; Takahashi H; Calne DB
    Neurology; 1997 Apr; 48(4):1053-6. PubMed ID: 9109899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
    Kuriakose R; Stoessl AJ
    Prog Brain Res; 2010; 184():177-92. PubMed ID: 20887875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
    Rinne JO; Hietala J; Ruotsalainen U; Säkö E; Laihinen A; Någren K; Lehikoinen P; Oikonen V; Syvälahti E
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):310-4. PubMed ID: 8436624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
    Vidailhet M; Dupel C; Lehéricy S; Remy P; Dormont D; Serdaru M; Jedynak P; Veber H; Samson Y; Marsault C; Agid Y
    Arch Neurol; 1999 Aug; 56(8):982-9. PubMed ID: 10448804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the ratio method compared with graphical analyses for estimating nigrostriatal function in human 18F-dopa PET studies with or without carbidopa.
    Otsuka M; Ichiya Y; Kuwabara Y; Fukumura T; Sasaki M; Masuda K
    Nucl Med Commun; 1993 Oct; 14(10):862-7. PubMed ID: 8233229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.